EcoDrugPlus

Insulin Receptor A

Ensembl ID : ENSOTSG00005031330
Gene Symbol: INSRA
1 Cross references
205 Possible Orthologues:

Insulin Receptor A

Ensembl ID : ENSOTSG00005033612
Gene Symbol: INSRA
1 Cross references
204 Possible Orthologues:

Insulin Receptor-Like

Ensembl ID : ENSOTSG00005012927
Gene Symbol: LOC112226585
3 Cross references
204 Possible Orthologues:

Insulin-Like Growth Factor 1a Receptor

Ensembl ID : ENSOTSG00005011441
Gene Symbol: IGF1RA
1 Cross references
198 Possible Orthologues:

Insulin-Like Growth Factor 1a Receptor

Ensembl ID : ENSOTSG00005036789
Gene Symbol: IGF1RA
1 Cross references
194 Possible Orthologues:

Integrin Alpha-4-Like

Ensembl ID : ENSOTSG00005030702
Gene Symbol: LOC112220187
2 Cross references
160 Possible Orthologues:

Integrin Alpha-4-Like

Ensembl ID : ENSOTSG00005020316
Gene Symbol: LOC112220187
2 Cross references
160 Possible Orthologues:

Integrin Alpha-4-Like

Ensembl ID : ENSOTSG00005019966
Gene Symbol: LOC112220187
2 Cross references
160 Possible Orthologues:

Integrin Alpha-4-Like

Ensembl ID : ENSOTSG00005037421
Gene Symbol: LOC112220187
2 Cross references
160 Possible Orthologues:

Integrin Alpha-4-Like

Ensembl ID : ENSOTSG00005029393
Gene Symbol: LOC112220187
2 Cross references
160 Possible Orthologues:

Integrin Alpha-Iib-Like

Ensembl ID : ENSOTSG00005001162
Gene Symbol: LOC112258495
3 Cross references
183 Possible Orthologues:

Integrin Beta 3a

Ensembl ID : ENSOTSG00005037668
Gene Symbol: ITGB3A
1 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).